The New Weight Management Meds
US$ 22.82
amylyx glp 1 Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think Ease your GLP BioCentury - Could amylin outshine
Description
Proportion of caloric restrictioninduced weight loss as skeletal muscle
View Agenda The GLP-1 market is on track to reach over $30 billion by 2030
But those of us who specialize in metabolic psychiatry, who work primarily with patients dealing with both obesity and mental health concerns, we should absolutely have this in our toolkit
M.EdwardsJ
Marketing and Community Engagement To make your GLP-1 program successful, people need to know it exists
